Replies to post #97859 on Anavex Life Sciences Corp (AVXL)

[drv17]

I believe it was Feb. 17th Just checked here is the info.

Q: Who is entitled to vote at the 2017 Meeting?
A: Holders of Anavex Life Sciences Corp.’s common stock, par value $0.001 per share (“Common Stock”), at the close of
business on February 17, 2017, the record date for the 2017 Meeting (the “Record Date”) established by our board of
directors (the “Board”), are entitled to receive notice of the 2017 Meeting (the “Meeting Notice”), and to vote their shares
at the 2017 Meeting and any related adjournments or postponements thereof. The Meeting Notice, proxy statement and
form of proxy card are first expected to be made available to stockholders on or about March 10, 2017.
As of the close of business on the Record Date, there were 41,123,790 shares of our Common Stock outstanding and
entitled to vote. Holders of our Common Stock are entitled to one (1) vote per share at the 2017 Meeting. Holders of the
Common Stock are collectively referred to herein as the Company’s “stockholders.” At the 2017 Meeting, there will be a
total of 41,123,790 possible votes with respect to the outstanding shares of capital stock entitled to vote at the Meeting

[mapman1010]

Q: Who is entitled to vote at the 2017 Meeting?


A: Holders of Anavex Life Sciences Corp.’s common stock, par value $0.001 per share (“ Common Stock ”), at the close of business on February 17, 2017, the record date for the 2017 Meeting (the “ Record Date ”) established by our board of directors (the “ Board ”), are entitled to receive notice of the 2017 Meeting (the “ Meeting Notice ”), and to vote their shares at the 2017 Meeting and any related adjournments or postponements thereof. The Meeting Notice, proxy statement and form of proxy card are first expected to be made available to stockholders on or about March 7, 2017.